Teva announces availability of moxifloxacin hydrochloride tablets

NORTH WALES, Pa. — Teva Pharmaceuticals announced the introduction of moxifloxacin hydrochloride tablets, the generic equivalent to Avelox tablets. The drug is available in 400-mg strength.

Moxifloxacin hydrochloride is used to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria, the company said.

"Generic pharmaceuticals are playing an increasingly important role in healthcare cost containment," said Maureen Cavanaugh, SVP U.S. generics sales and marketing. "Teva Pharmaceuticals continues to lead the way with timely new product launches."


Login or Register to post a comment.